Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gilson

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Sexually Transmitted Infections|April 28, 2018
Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016Janey Sewell, Valentina Cambiano, Ada Miltz, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 28, 2019
Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017Michael Edelstein, Nalini Iyanger, Nicola Hennessy, et al.
BMC Medical Research Methodology|November 8, 2018
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)Macey L Murray, Jade Meadows, Caroline J Doré, et al.
The Journal of Infectious Diseases|September 20, 2005
The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort studyColette J Smith, Andrew N Phillips, Teresa Hill, et al.
Plos One|May 30, 2014
Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naïve to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmissionAlison J Rodger, Andrew Phillips, Andrew Speakman, et al.
AIDS (London, England)|October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIVJames E Burns, Oliver T Stirrup, David Dunn, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2015
Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapyAlan Winston, Sophie Jose, Martin Fisher, et al.
Plos One|March 4, 2025
Transitions in sexual behaviour among gay, bisexual, and other men who have sex with men in England: Data from a prospective studyNadia Hanum, Valentina Cambiano, Janey Sewell, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
The interaction between chronic hepatitis B (CHB) and Metabolic dysfunction-associated steatotic liver disease (MASLD) in a diverse central London populationEmily Martyn, Claire Mullender, Stephen Ogunnaike, et al.
Plos One|November 13, 2012
Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) studyHuw Price, Loveleen Bansi, Caroline A Sabin, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Sexually Transmitted Infections|April 28, 2018
Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016Janey Sewell, Valentina Cambiano, Ada Miltz, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 28, 2019
Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017Michael Edelstein, Nalini Iyanger, Nicola Hennessy, et al.
BMC Medical Research Methodology|November 8, 2018
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)Macey L Murray, Jade Meadows, Caroline J Doré, et al.
The Journal of Infectious Diseases|September 20, 2005
The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort studyColette J Smith, Andrew N Phillips, Teresa Hill, et al.
Plos One|May 30, 2014
Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naïve to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmissionAlison J Rodger, Andrew Phillips, Andrew Speakman, et al.
AIDS (London, England)|October 1, 2019
No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIVJames E Burns, Oliver T Stirrup, David Dunn, et al.
The Journal of Allergy and Clinical Immunology|August 9, 2015
Host, disease, and antiretroviral factors are associated with normalization of the CD4:CD8 ratio after initiating antiretroviral therapyAlan Winston, Sophie Jose, Martin Fisher, et al.
Plos One|March 4, 2025
Transitions in sexual behaviour among gay, bisexual, and other men who have sex with men in England: Data from a prospective studyNadia Hanum, Valentina Cambiano, Janey Sewell, et al.
Medrxiv : the Preprint Server for Health Sciences|June 29, 2026
The interaction between chronic hepatitis B (CHB) and Metabolic dysfunction-associated steatotic liver disease (MASLD) in a diverse central London populationEmily Martyn, Claire Mullender, Stephen Ogunnaike, et al.
Plos One|November 13, 2012
Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) studyHuw Price, Loveleen Bansi, Caroline A Sabin, et al.
Pageof 15